Table 2 Clinical and therapeutic data of the study SLE patients (n = 103)

Age at diagnosis (years)

24.82 ± 8.49

Diseases duration (years)

4 (1–39)

Clinical manifestations

Psychiatric diagnosis

11 (10.7)

Seizures

11 (10.7)

Stroke

6 (5.8)

Biopsy proven nephritis

12 (11.7)

Dialysis

3 (2.9)

Disease activity (SLEDAI)

No

Mild

Moderate

Sever

19 (18.4)

37 (35.9)

39 (37.9)

8 (7.8)

SLE medication classes

Steroids

83 (80.6)

Antimalarials

56 (54.4)

Azathioprine

54 (52.4)

Mycophenolate Mofetil

23 (22.3)

Methotrexate

21 (20.4)

Biologics

9 (8.7)